Palmer Olivia R, Shaydakov Maxim E, Rainey Joshua P, Lawrence Daniel A, Greve Joan M, Diaz José A
Department of Biomedical Engineering University of Michigan Ann Arbor MI USA.
Department of Surgery, Vascular Surgery University of Michigan Ann Arbor MI USA.
Res Pract Thromb Haemost. 2018 Jan 31;2(2):266-273. doi: 10.1002/rth2.12074. eCollection 2018 Apr.
The electrolytic inferior vena cava model (EIM) is a murine venous thrombosis (VT) model that produces a non-occlusive thrombus. The thrombus forms in the direction of blood flow, as observed in patients. The EIM is valuable for investigations of therapeutics due to the presence of continuous blood flow. However, the equipment used to induce thrombosis in the original model description was expensive and has since been discontinued. Further, the fibrinolytic system had not been previously studied in the EIM.
We aimed to provide an equipment alternative. Additionally, we further characterized the model through mapping the current and time dependency of thrombus resolution dynamics, and investigated the fibrinolytic system from acute to chronic VT.
A voltage to current converter powered by a direct current power supply was constructed and validated, providing an added benefit of significantly reducing costs. The current and time dependency of thrombus volume dynamics was assessed by MRI, demonstrating the flexibility of the EIM to investigate both pro-thrombotic and anti-thrombotic conditions. Additionally, the fibrinolytic system was characterized in EIM. Centripetal distribution of plasminogen was observed over time, with peak staining at day 6 post thrombus induction. Both active circulating plasminogen activator inhibitor-1 (PAI-1) and vein wall gene expression of PAI-1 peaked at day 2, coinciding with a relative decrease in tissue plasminogen activator and urokinase plasminogen activator.
The EIM is a valuable model of VT that can now be performed at low cost and may be beneficial in investigations of the fibrinolytic system.
电解下腔静脉模型(EIM)是一种产生非闭塞性血栓的小鼠静脉血栓形成(VT)模型。如在患者中观察到的那样,血栓沿血流方向形成。由于存在持续血流,EIM对于治疗研究具有重要价值。然而,原始模型描述中用于诱导血栓形成的设备昂贵且已停产。此外,此前尚未在EIM中研究过纤维蛋白溶解系统。
我们旨在提供一种替代设备。此外,我们通过绘制血栓溶解动力学的电流和时间依赖性来进一步表征该模型,并研究从急性到慢性VT的纤维蛋白溶解系统。
构建并验证了由直流电源供电的电压 - 电流转换器,具有显著降低成本的额外优势。通过MRI评估血栓体积动力学的电流和时间依赖性,证明了EIM在研究促血栓形成和抗血栓形成条件方面的灵活性。此外,对EIM中的纤维蛋白溶解系统进行了表征。观察到纤溶酶原随时间向心分布,在血栓形成后第6天染色峰值出现。活性循环纤溶酶原激活物抑制剂-1(PAI-1)和PAI-1的静脉壁基因表达均在第2天达到峰值,与组织纤溶酶原激活物和尿激酶纤溶酶原激活物的相对减少相吻合。
EIM是一种有价值的VT模型,现在可以低成本进行,并且可能有利于纤维蛋白溶解系统的研究。